
Celanese (CE) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
2.5B
Gross Profit
535.0M
21.13%
Operating Income
249.0M
9.83%
Net Income
202.0M
7.98%
EPS (Diluted)
$1.81
Balance Sheet Metrics
Total Assets
23.7B
Total Liabilities
18.0B
Shareholders Equity
5.7B
Debt to Equity
3.16
Cash Flow Metrics
Operating Cash Flow
26.0M
Free Cash Flow
-65.0M
Revenue & Profitability Trend
Celanese Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 10.3B | 10.9B | 9.7B | 8.5B | 5.7B |
Cost of Goods Sold | 7.9B | 8.3B | 7.3B | 5.9B | 4.4B |
Gross Profit | 2.4B | 2.6B | 2.4B | 2.7B | 1.3B |
Gross Margin % | 22.9% | 23.8% | 24.6% | 31.4% | 22.9% |
Operating Expenses | |||||
Research & Development | 130.0M | 146.0M | 112.0M | 86.0M | 74.0M |
Selling, General & Administrative | 1.0B | 1.1B | 824.0M | 633.0M | 482.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 1.2B | 1.2B | 936.0M | 719.0M | 556.0M |
Operating Income | 1.0B | 1.2B | 1.4B | 1.9B | 715.0M |
Operating Margin % | 10.1% | 11.1% | 14.3% | 22.7% | 12.6% |
Non-Operating Items | |||||
Interest Income | 33.0M | 39.0M | 69.0M | 8.0M | 6.0M |
Interest Expense | 676.0M | 720.0M | 405.0M | 91.0M | 109.0M |
Other Non-Operating Income | -1.4B | 653.0M | 375.0M | 402.0M | 1.6B |
Pre-tax Income | -996.0M | 1.2B | 1.4B | 2.2B | 2.3B |
Income Tax | 510.0M | -790.0M | -489.0M | 330.0M | 247.0M |
Effective Tax Rate % | 0.0% | -66.8% | -34.4% | 14.7% | 11.0% |
Net Income | -1.5B | 2.0B | 1.9B | 1.9B | 2.0B |
Net Margin % | -14.7% | 18.0% | 19.7% | 22.2% | 35.2% |
Key Metrics | |||||
EBITDA | 2.1B | 2.0B | 2.2B | 2.6B | 1.2B |
EPS (Basic) | $-13.93 | $18.01 | $17.48 | $16.99 | $16.85 |
EPS (Diluted) | $-13.93 | $17.92 | $17.34 | $16.86 | $16.75 |
Basic Shares Outstanding | 109300000 | 108800000 | 108400000 | 111200000 | 117800000 |
Diluted Shares Outstanding | 109300000 | 108800000 | 108400000 | 111200000 | 117800000 |
Income Statement Trend
Celanese Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 962.0M | 1.8B | 1.5B | 536.0M | 955.0M |
Short-term Investments | - | - | - | 10.0M | 533.0M |
Accounts Receivable | 1.1B | 1.2B | 1.4B | 1.2B | 792.0M |
Inventory | 2.3B | 2.4B | 2.8B | 1.5B | 978.0M |
Other Current Assets | 285.0M | 272.0M | 241.0M | 80.0M | 55.0M |
Total Current Assets | 5.1B | 6.2B | 6.6B | 3.8B | 3.8B |
Non-Current Assets | |||||
Property, Plant & Equipment | 388.0M | 422.0M | 413.0M | 236.0M | 232.0M |
Goodwill | 14.4B | 17.9B | 18.4B | 3.6B | 2.7B |
Intangible Assets | 3.6B | 4.0B | 4.1B | 735.0M | 319.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 1.8B | 2.2B | 1.4B | 769.0M | 670.0M |
Total Non-Current Assets | 17.7B | 20.4B | 19.7B | 8.2B | 7.1B |
Total Assets | 22.9B | 26.6B | 26.3B | 12.0B | 10.9B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.2B | 1.5B | 1.5B | 1.2B | 797.0M |
Short-term Debt | 1.6B | 1.5B | 1.4B | 828.0M | 532.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 478.0M | 395.0M | 468.0M | 122.0M | 253.0M |
Total Current Liabilities | 3.9B | 4.1B | 4.1B | 2.5B | 2.0B |
Non-Current Liabilities | |||||
Long-term Debt | 11.4B | 12.6B | 13.7B | 3.4B | 3.4B |
Deferred Tax Liabilities | 933.0M | 999.0M | 1.2B | 555.0M | 509.0M |
Other Non-Current Liabilities | 408.0M | 591.0M | 387.0M | 164.0M | 214.0M |
Total Non-Current Liabilities | 13.4B | 15.0B | 16.1B | 4.9B | 5.0B |
Total Liabilities | 17.2B | 19.0B | 20.2B | 7.4B | 7.0B |
Equity | |||||
Common Stock | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 11.1B | 12.9B | 11.3B | 9.7B | 8.1B |
Treasury Stock | 5.5B | 5.5B | 5.5B | 5.5B | 4.5B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 5.6B | 7.6B | 6.1B | 4.5B | 3.9B |
Key Metrics | |||||
Total Debt | 13.0B | 14.1B | 15.1B | 4.2B | 4.0B |
Working Capital | 1.3B | 2.1B | 2.5B | 1.3B | 1.8B |
Balance Sheet Composition
Celanese Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -1.5B | 2.0B | 1.9B | 1.9B | 2.0B |
Depreciation & Amortization | 823.0M | 739.0M | 478.0M | 378.0M | 356.0M |
Stock-Based Compensation | 32.0M | 40.0M | 60.0M | 95.0M | 28.0M |
Working Capital Changes | -204.0M | 516.0M | 280.0M | -488.0M | 280.0M |
Operating Cash Flow | -676.0M | 2.3B | 1.8B | 1.7B | 2.6B |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | 0 | 532.0M | -10.5B | -1.1B | 1.5B |
Investment Purchases | - | - | 0 | 0 | -544.0M |
Investment Sales | 17.0M | 0 | 0 | 516.0M | 43.0M |
Investing Cash Flow | -35.0M | 434.0M | -10.6B | -652.0M | 956.0M |
Financing Activities | |||||
Share Repurchases | 0 | 0 | -17.0M | -1.0B | -650.0M |
Dividends Paid | -307.0M | -305.0M | -297.0M | -304.0M | -293.0M |
Debt Issuance | 328.0M | 3.0B | 10.8B | 990.0M | 0 |
Debt Repayment | -1.5B | -4.5B | -526.0M | -792.0M | -783.0M |
Financing Cash Flow | -1.7B | -2.3B | 10.3B | -1.0B | -2.2B |
Free Cash Flow | 531.0M | 1.3B | 1.3B | 1.3B | 979.0M |
Net Change in Cash | -2.4B | 362.0M | 1.5B | 35.0M | 1.3B |
Cash Flow Trend
Celanese Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
6.78
Forward P/E
4.69
Price to Book
0.94
Price to Sales
0.50
PEG Ratio
0.24
Profitability Ratios
Profit Margin
-16.30%
Operating Margin
9.87%
Return on Equity
-23.80%
Return on Assets
2.48%
Financial Health
Current Ratio
2.05
Debt to Equity
233.42
Beta
1.13
Per Share Data
EPS (TTM)
$-14.64
Book Value per Share
$48.18
Revenue per Share
$90.84
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ce | 4.9B | 6.78 | 0.94 | -23.80% | -16.30% | 233.42 |
Dow | 16.9B | 75.93 | 0.98 | -4.74% | -2.35% | 97.39 |
Methanex | 3.0B | 11.07 | 1.14 | 12.88% | 7.04% | 128.81 |
Olin | 3.0B | 40.21 | 1.51 | -0.80% | -0.21% | 165.21 |
Huntsman | 1.6B | 46.18 | 0.57 | -7.79% | -5.75% | 79.58 |
Rex American | 1.0B | 21.37 | 1.92 | 10.30% | 7.91% | 3.90 |
Financial data is updated regularly. All figures are in the company's reporting currency.